Doceree 360 (2025 Edition) shows clinicians now prioritize credibility, context and patient impact over volume-driven digital engagement.
Healthcare is entering a cognitive era. And the rules of engagement have fundamentally changed.
As artificial intelligence rapidly reshapes clinical practice, the Doceree 360 report: HCP Engagement in the Age of AI (2025 Edition) reveals a decisive shift in how healthcare professionals (HCPs) want to engage with AI-powered tools and pharmaceutical brands.
The finding is striking: 89% of HCPs say they want "assured intelligence" — AI that is credible, clinically verified, and contextually relevant — rather than more generic AI solutions.
Drawing on insights from a Q4 2025 HCP survey conducted on Doceree.ai alongside global industry research, the report documents that healthcare is undergoing a cognitive transformation, not merely a digital one. With 66% of physicians now using AI in their daily practice, clinicians' expectations have evolved at unprecedented speed — while much of pharma's engagement strategy remains optimized for a pre-AI world.
"AI has fundamentally changed how clinicians think, not just how they consume information," said Harshit Jain, MD, Founder and Global CEO, Doceree. "The Doceree 360 report shows that HCPs are raising the bar — demanding intelligence that is credible, contextual, and capable of improving patient outcomes in real time. Pharma engagement strategies must evolve accordingly."
The Doceree 360 report identifies three major behavioral shifts among HCPs — and the strategic imperatives pharma brands must adopt in response:
The Shift: With 89% of HCPs demanding assured AI over generic solutions, clinicians are making it clear: they're not interested in volume. They want credibility.
HCPs now expect AI outputs that are evidence-backed, auditable, and clinically validated. Speed without credibility no longer influences decision-making. The bar has moved from "fast answers" to "trustworthy intelligence."
Strategic Response for Pharma:
Move beyond promotional content to deliver clinically validated, AI-powered insights that meet the highest standards of medical credibility. This means investing in verification frameworks, clinical evidence integration, and transparent sourcing.
The Shift: The Doceree survey found that 83% of HCPs no longer learn in isolated environments, signaling the death of traditional continuing medical education models.
HCP learning has become adaptive and moment-driven. Instead of attending scheduled webinars or reading static content, clinicians expect concise, relevant insights delivered seamlessly across research platforms, medical journals, EHR systems, and point-of-care workflows — exactly when and where they need them.
Strategic Response for Pharma:
Integrate engagement directly into the clinical workflow. This means embedding intelligent content within EHRs, medical literature platforms, and diagnostic tools where HCPs are already making decisions — rather than asking them to leave their workflow to consume brand messaging.
The Shift: 78% of healthcare professionals prioritize immediate, actionable patient impact over theoretical knowledge, according to the Doceree survey.
As AI accelerates clinical workflows, HCPs can now identify solutions faster — but access, affordability, and operational barriers stand out more sharply. Clinicians increasingly engage with brands and content that help them remove friction and improve real-world patient outcomes.
Strategic Response for Pharma:
Transition from awareness campaigns to real-time clinical decision support. Provide HCPs with affordability intelligence, access solutions, formulary guidance, and patient support resources at the moment of prescribing. Become a partner in care delivery, not just a source of product information.
The Widening Strategy Gap
While HCP behavior is modernizing at extraordinary speed, the Doceree 360 report finds that much of pharma's engagement infrastructure remains fundamentally misaligned:
"We're witnessing the emergence of what we call the 'expectation economy of healthcare,'" Jain explained. "HCPs have raised their expectations exponentially, and pharma brands must close the gap between how clinicians work today and how brands are still trying to engage them."
The Doceree 360 report outlines clear imperatives for pharmaceutical marketers ready to embrace the cognitive era:
✓ Deliver credible, compliant AI-driven content with clinical validation at its core
✓ Engage HCPs through context-first interactions, not channel saturation
✓ Shift from promotion to patient-impact enablement, including real-time access and affordability intelligence
✓ Measure engagement predictively, not retrospectively
✓ Build continuous intelligence systems, not campaign-based marketing
"The brands that will win HCP mindshare in the coming years are those that embrace a fundamental truth: AI has changed how clinicians think, and pharma must change how it communicates," added Kamya Elawadhi, Chief Client Officer, Doceree. "This isn't about adding AI features to existing strategies—it's about rethinking engagement from the ground up with assured intelligence at the core."
Looking ahead - predictions for 2026-27
The report concludes with forward-looking predictions on trends poised to redefine global healthcare engagement:
The brands that will win HCP mindshare in the coming years are those that embrace a simple truth: AI has changed how clinicians think — and pharma must change how it communicates.
Pharma brands that adapt will evolve from information providers to trusted partners in care. Those that don't risk becoming irrelevant in an era where HCPs have unlimited access to information — but limited patience for anything that doesn't meet their new standard of assured intelligence.